Salt and Cocrystals Combining Sulfathiazole with Pyrimethamine

Résultats de recherche: Contribution à un journal/une revueArticleRevue par des pairs


Dihydrofolate reductase inhibitors, such as pyrimethamine, are known to have synergistic effects with sulfonamides. Four new solid forms combining pyrimethamine and sulfathiazole, one cocrystal (pyrimethamine-sulfathiazole (1:1)) and three solvated salt cocrystals (in which pyrimethamine and sulfathiazole are in a 1:2 molar ratio), are determined and characterized. Desolvation of the salt cocrystals leads to either a physical mixture of the starting compounds or the formation of the cocrystal (1:1) with an excess of sulfathiazole. The pyrimethamine sulfathiazole binary phase diagram was determined, which reveals that the pyrimethamine-sulfathiazole (1:2) composition point corresponds to a metastable eutectic. Obtaining this metastable eutectic as a pure powder is therefore rather difficult since it converts to a stable mixture of the (1:1) cocrystal + sulfathiazole. The abovementioned drug-drug multicomponent systems are characterized in terms of thermal stability (by TGA/DSC) and solubility. Both pyrimethamine-sulfathiazole (1:1) cocrystal and pyrimethamine-sulfathiazole (1:2) ethanol-solvated salt cocrystal result in an increase of the parent drugs’ solubility.

langue originaleAnglais
Pages (de - à)7811-7820
Nombre de pages10
journalCrystal Growth and Design
Numéro de publication11
Les DOIs
Etat de la publicationPublié - 1 nov. 2023
Modification externeOui

Empreinte digitale

Examiner les sujets de recherche de « Salt and Cocrystals Combining Sulfathiazole with Pyrimethamine ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation